Wolverine Trading’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-171
| Closed | -$3.39K | – | 5204 |
|
|
2023
Q3 | $3.39K | Buy |
171
+62
| +57% | +$2.67K | ﹤0.01% | 4386 |
|
|
2023
Q2 | $8.06K | Sell |
109
-56
| -34% | -$4.53K | ﹤0.01% | 4146 |
|
|
2023
Q1 | $16K | Sell |
165
-540
| -77% | -$51.4K | ﹤0.01% | 4036 |
|
|
2022
Q4 | $69K | Sell |
705
-30
| -4% | -$4.35K | ﹤0.01% | 3512 |
|
|
2022
Q3 | $218K | Buy |
735
+390
| +113% | +$113K | ﹤0.01% | 3516 |
|
|
2022
Q2 | $64K | Buy |
345
+185
| +116% | +$17.7K | ﹤0.01% | 3994 |
|
|
2022
Q1 | $16K | Sell |
160
-397
| -71% | -$51K | ﹤0.01% | 5268 |
|
|
2021
Q4 | $94K | Buy |
+557
| New | +$122K | ﹤0.01% | 5117 |
|
|
2021
Q3 | – | Sell |
-362
| Closed | -$146K | – | 6937 |
|
|
2021
Q2 | $146K | Sell |
362
-437
| -55% | -$204K | ﹤0.01% | 5215 |
|
|
2021
Q1 | $404K | Buy |
799
+514
| +180% | +$320K | ﹤0.01% | 4035 |
|
|
2020
Q4 | $113K | Sell |
285
-58
| -17% | -$23.1K | ﹤0.01% | 4432 |
|
|
2020
Q3 | $132K | Sell |
343
-329
| -49% | -$145K | ﹤0.01% | 4034 |
|
|
2020
Q2 | $324K | Sell |
672
-315
| -32% | -$140K | ﹤0.01% | 3244 |
|
|
2020
Q1 | $377K | Buy |
987
+259
| +36% | +$134K | ﹤0.01% | 2968 |
|
|
2019
Q4 | $523K | Sell |
728
-276
| -27% | -$190K | ﹤0.01% | 3029 |
|
|
2019
Q3 | $636K | Buy |
1,004
+205
| +26% | +$163K | ﹤0.01% | 2384 |
|
|
2019
Q2 | $699K | Sell |
799
-350
| -30% | -$241K | ﹤0.01% | 2375 |
|
|
2019
Q1 | $663K | Sell |
1,149
-87
| -7% | -$36.4K | ﹤0.01% | 2473 |
|
|
2018
Q4 | $308K | Buy |
+1,236
| New | +$489K | ﹤0.01% | 3152 |
|
|
2018
Q3 | – | Sell |
-376
| Closed | -$221K | – | 5854 |
|
|
2018
Q2 | $221K | Hold |
376
| – | – | ﹤0.01% | 4236 |
|
|
2018
Q1 | $221K | Sell |
376
-33
| -8% | -$20.6K | ﹤0.01% | 4236 |
|
|
2017
Q4 | $254K | Buy |
409
+102
| +33% | +$73.3K | ﹤0.01% | 3840 |
|
|
2017
Q3 | $283K | Buy |
+307
| New | +$273K | ﹤0.01% | 3342 |
|
|
2017
Q2 | – | Sell |
-779
| Closed | -$753K | – | 4945 |
|
|
2017
Q1 | $753K | Sell |
779
-489
| -39% | -$455K | ﹤0.01% | 1967 |
|
|
2016
Q4 | $1.02M | Buy |
1,268
+290
| +30% | +$261K | 0.01% | 1900 |
|
|
2016
Q3 | $819K | Sell |
978
-635
| -39% | -$510K | ﹤0.01% | 2084 |
|
|
2016
Q2 | $1.4M | Buy |
+1,613
| New | +$1.76M | 0.01% | 1346 |
|
Other funds holding TCRT
MP
DCM
MCA
Wolverine Trading's TCRT Position: Q3 2023 in Review
Wolverine Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 158 shares — an estimated $6.81K sold.
Wolverine Trading first reported a position in TCRT in Q2 2016 and held it in 23 quarters. The position peaked at $557K in Q2 2019. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.
- Wolverine Trading reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
- Wolverine Trading sold 158 Alaunos Therapeutics shares in Q3 2023, an estimated $6.81K.
- Wolverine Trading first reported a position in Alaunos Therapeutics in Q2 2016 and held it in 23 quarters.
- Wolverine Trading's Alaunos Therapeutics position peaked at $557K in Q2 2019.
- 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.
Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.